Skip to main content
. 2023 Sep 12;26(1):7–24. doi: 10.1093/neuonc/noad154

Figure 1.

Figure 1.

Representative example of increasing seizure frequency aligning with tumor progression in a patient with recurrent oligodendroglioma despite ASM changes. CBM, cenobamate; LCM, lacosamide; LEV, levetiracetam; OXC, oxcarbazepine.